Boston, MA, United States of America

Jennifer L Kanter

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jennifer L Kanter

Introduction

Jennifer L Kanter is a prominent inventor based in Boston, MA (US). She has made significant strides in the field of medical research, particularly in the treatment of autoimmune diseases. Her work has the potential to improve the lives of many patients suffering from conditions like multiple sclerosis.

Latest Patents

Jennifer holds a patent for a groundbreaking method of treating multiple sclerosis with phosphocholine containing lipids. This innovative approach involves the development of lipid microarrays to perform large-scale multiplex analysis of lipid-specific binding. The lipids identified as disease-associated or their analogs can be tolerogenic to patients suffering from autoimmune diseases. Her lipid array analysis has revealed anti-lipid antibodies in patients with immune disorders, which may contribute to the pathogenesis of these diseases.

Career Highlights

Throughout her career, Jennifer has worked with esteemed institutions, including Leland Stanford Junior University and the United States Government as represented by the Department of Veterans Affairs. Her research has garnered attention for its potential impact on understanding and treating autoimmune diseases.

Collaborations

Jennifer has collaborated with notable individuals in her field, including William H Robinson and Lawrence Steinman. These partnerships have furthered her research and contributed to the advancement of knowledge in lipid analysis and autoimmune disease treatment.

Conclusion

Jennifer L Kanter's innovative work in the treatment of multiple sclerosis showcases her dedication to advancing medical research. Her contributions have the potential to significantly impact the lives of patients with autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…